Literature DB >> 7653568

Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver.

J X Zhang1, M Bauer, M G Clemens.   

Abstract

We studied the sinusoidal and extrasinusoidal constrictor response of hepatic microcirculation to endothelin-1 (ET-1) and endothelin-3 (ET-3) and the possible role of Ito cells vs. Kupffer cells or endothelial cells in mediating this response, using isolated rat livers under high-power intravital microscopy. Rats were pretreated by injection of 2.6 x 10(8) fluorescent latex beads (1 micron) intravenously to label Kupffer cells. Three hours later livers were isolated and perfused before and during the infusion of 1 nM ET-1 or ET-3 with or without the endothelin type A (ETA) receptor antagonist BQ-123 or ETB antagonist IRL-1038. Alternatively, the perfused livers were infused with the ETB agonist sarafotoxin 6c (S6c, 1 or 5 nM). Sinusoid diameters were quantitated at the sites of Ito cells (identified by vitamin A fluorescence) or Kupffer cells (phagocytosed fluorescent latex beads) or where neither cell type was found (endothelial cells). ET-1 was found to induce significant sinusoid constriction at the sites of Ito cells (13.21 +/- 0.58 microns control vs. 10.47 +/- 0.48 microns during ET-1 infusion) but not at the sites of Kupffer cells or endothelial cells (13.26 +/- 0.79 vs. 12.92 +/- 0.61 microns and 12.20 +/- 0.71 vs. 11.98 +/- 0.40 microns, respectively), whereas neither ET-3 nor S6c had any effect on sinusoid narrowing, despite a 1.8-fold (ET-3) or 5.6-fold (5 nM S6c) greater increase in total portal resistance compared with ET-1.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7653568     DOI: 10.1152/ajpgi.1995.269.2.G269

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

1.  Reversal of the vasoconstrictor step of hyperacute xenogeneic rejection of the liver by endothelin antagonists.

Authors:  B Zhang; L Wen; A Gomola; P P Massault; B Cherruau; D Houssin; B Weill; Y Calmus
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

3.  Effects of mixed ETA and ETB-receptor antagonist (Ro-47-0203) on hepatic microcirculation after warm ischemia.

Authors:  T A Koeppel; T Kraus; J C Thies; M M Gebhard; G Otto; S Post
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

4.  Hepatic alterations during the development and progression of cancer cachexia.

Authors:  Megan E Rosa-Caldwell; Jacob L Brown; David E Lee; Michael P Wiggs; Richard A Perry; Wesley S Haynie; Aaron R Caldwell; Tyrone A Washington; Wen-Juo Lo; Nicholas P Greene
Journal:  Appl Physiol Nutr Metab       Date:  2019-10-16       Impact factor: 2.665

5.  Endotoxin causes up-regulation of endothelin receptors in cultured hepatic stellate cells via nitric oxide-dependent and -independent mechanisms.

Authors:  C R Gandhi; T Uemura; R Kuddus
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 6.  Role of intrahepatic innervation in regulating the activity of liver cells.

Authors:  Letitia Adela Maria Streba; Cristin Constantin Vere; Alin Gabriel Ionescu; Costin Teodor Streba; Ion Rogoveanu
Journal:  World J Hepatol       Date:  2014-03-27

7.  Effect of selective blockade of endothelin ETB receptors on the liver dysfunction and injury caused by endotoxaemia in the rat.

Authors:  H Ruetten; C Thiemermann
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

8.  Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats.

Authors:  B H Pannen; N Köhler; B Hole; M Bauer; M G Clemens; K K Geiger
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

Review 9.  Stellate cell contraction: role, regulation, and potential therapeutic target.

Authors:  Russell K Soon; Hal F Yee
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

10.  Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.

Authors:  C Thirunavukkarasu; Y Yang; V M Subbotin; S A K Harvey; J Fung; C R Gandhi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.